Sign in or Join FriendFeed
FriendFeed is the easiest way to share online. Learn more »
Libby's H*O*P*E*

Libby's H*O*P*E*

Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education). To learn more go to
BRCA Screening: Good Sense or Gattaca Rising? .....-
Researchers develop new 'designer proteins' in fight against Alzheimer's and cancer. .... — University of Leicester -
New Anticancer Peptide Vaccines and Inhibitors Developed by Ohio State Researchers. ..... -
Targeted therapies: Insights from exceptional responders. ..... : Nature Reviews Cancer : Nature Publishing Group -
Summing it up: An integrative review of studies of cancer survivorship care plans (2006-2013). ..... - Mayer - 2014 - Cancer - Wiley Online Library -
Rice University study yields new two-step strategy for weakening cancer. ..... -
NIH funds next phase of Tissue Chip for Drug Screening program. .... -
Solitomab may represent a novel, potentially effective agent for the treatment of chemotherapy-resistant ovarian cancers that overexpress EpCAM. .....- 2014 - Cancer - Wiley Online Library -
Obesity is associated with worse quality of life in women with gynecologic malignancies: An opportunity to improve patient-centered outcomes. ...... - Doll - 2014 - Cancer - Wiley Online Library -
XenOPAT, mouse models for personalized cancer treatment. ..... -
New chip promising for tumor-targeting research. ....... -
Future Approaches in Immunotherapy. ...... - Seminars in Oncology -
Molecular Testing for Cancer Therapy Varies Based on Ethnicity. ..... : PracticeUpdate -
Match Cancer Genome to Treatment. .....The Daily Scan | GenomeWeb -
Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). ...... [Ann Surg Oncol. 2014] - PubMed - NCBI -
Cell fate regulation by gelsolin in human gynecologic cancers.... [Proc Natl Acad Sci U S A. 2014] - PubMed - NCBI -
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium. ..... [Onco Targets Ther. 2014] - PubMed - NCBI -
BRCA1/2 Mutation Status Is an Independent Factor of Improved Survival for Advanced (Stage III-IV) Ovarian Cancer. ...... [Int J Gynecol Cancer. 2014] - PubMed - NCBI -
Computed Tomography-Guided 125I Seed Interstitial Implantation in the Treatment of Recurrent Ovarian Cancer. ..... [Int J Gynecol Cancer. 2014] - PubMed - NCBI -
Deregulation of miR-128 in Ovarian Cancer Promotes Cisplatin Resistance.... [Int J Gynecol Cancer. 2014] - PubMed - NCBI -
ImmunoCellular Therapeutics Expands Cancer Immunotherapy Platform with Antigen-Specific T-cell Technology Licensed from Caltech. ....
The technology utilizes the patient's own hematopoietic stem cells to create antigen-specific killer T-cells to treat cancer. ImmunoCellular pipeline also includes ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells. - Libby's H*O*P*E*
Exercise improves chemotherapy treatment, Penn study finds. ...... | Penn Current -
FDA warns public about herbal capsule "chemotherapy". ..... | Inquirer Lifestyle -
Ivermectin could improve response to ovarian cancer anti-hormone therapy. ..... | FIGO -
Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2. ......
Stanford Researchers Create “Evolved” Protein That May Stop Breast & Ovarian Cancers From Spreading -
Professor, Molecular Neurobiology Laboratory, Françoise Gilot-Salk Chair
Metastatic Ovarian Cancer Therapeutics Pipeline Review 2014: 8 Companies and 11 Drug Profiles - Press Release - Digital Journal -
PHA launches ovarian cancer awareness programme. ..... | HSC Public Health Agency -
Acceleron Provides Update on Externally Sponsored Clinical Trial of Dalantercept (anti-angiogenesis ALK1 inhibitor) Monotherapy in Ovarian Cancer. ......
Multiple Factors Impact BRCA Testing Decision. .... -
Other ways to read this feed:Feed readerFacebook